Trial Profile
An Observational study to evaluate the efficacy of Everolimus in infants with cardiac rhabdomyomas associated to Tuberous sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Tuberous sclerosis
- Focus Therapeutic Use
- 17 Apr 2017 New trial record